TASSO, BRUNO
 Distribuzione geografica
Continente #
EU - Europa 8.364
AS - Asia 491
SA - Sud America 67
NA - Nord America 38
AF - Africa 7
Totale 8.967
Nazione #
IT - Italia 8.352
SG - Singapore 215
CN - Cina 158
VN - Vietnam 87
BR - Brasile 36
US - Stati Uniti d'America 25
AR - Argentina 17
HK - Hong Kong 12
MX - Messico 10
ID - Indonesia 5
PY - Paraguay 5
IQ - Iraq 4
RU - Federazione Russa 4
ZA - Sudafrica 4
SE - Svezia 3
UY - Uruguay 3
BD - Bangladesh 2
CA - Canada 2
CO - Colombia 2
MA - Marocco 2
PK - Pakistan 2
VE - Venezuela 2
AL - Albania 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GB - Regno Unito 1
IN - India 1
JP - Giappone 1
KG - Kirghizistan 1
KZ - Kazakistan 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 8.967
Città #
Genova 4.298
Genoa 2.658
Rapallo 737
Vado Ligure 620
Singapore 80
Beijing 34
Ho Chi Minh City 34
Bordighera 23
Hanoi 20
Tianjin 17
Ashburn 12
Hong Kong 12
Florence 8
Mexico City 7
Hangzhou 5
Da Nang 4
Biên Hòa 3
Montevideo 3
Ninh Bình 3
Phủ Lý 3
Asunción 2
Belo Horizonte 2
Camerino 2
Clorinda 2
Hải Dương 2
José Bonifácio 2
Kenitra 2
Los Angeles 2
Manaus 2
Milan 2
Nam Định 2
Recife 2
Stockholm 2
São Paulo 2
Almaty 1
Angered 1
Aracaju 1
Aracati 1
Arraias 1
Baghdad 1
Baoding 1
Brits 1
Buenos Aires 1
Bình Dương 1
Bắc Giang 1
Caacupé 1
Caloocan City 1
Camaçari 1
Campo Grande 1
Canoas 1
Cao Lanh 1
Caracas 1
Chacabuco 1
Chicago 1
City of London 1
Colombo 1
Coro 1
Couva 1
Curado 1
Dakar 1
Dali 1
Del Viso 1
Denver 1
Dhaka 1
Erbil 1
Gravina di Catania 1
Guangzhou 1
Guiyang 1
Haiphong 1
Hamad Town 1
Honolulu 1
Hortolândia 1
Hưng Yên 1
Iguape 1
Ilhéus 1
Itajaí 1
Ituzaingó 1
Jakarta 1
Jiaxing 1
Johannesburg 1
Kaliningrad 1
Kasur 1
Kediri 1
Kennedy 1
Košice 1
La Plata 1
Lavras 1
Lima 1
Lushnjë 1
Luziânia 1
Lấp Vò 1
Mendoza 1
Monte Grande 1
Montreal 1
Morrinhos 1
Moscow 1
Mountain View 1
Najaf 1
Nanyang 1
Natal 1
Totale 8.675
Nome #
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 233
Antiviral activity of benzimidazole derivatives. II Antiviral activity of 2-phenylbenzimidazole derivatives. 210
Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives 199
Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools 197
Acridine derivatives as anti-BVDV agents 187
Quinolizidinyl-benzimidazoles as platelet-antiaggregating agents 184
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 184
Benzimidazole derivatives endowed with potent antileishmanial activity 181
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells 175
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation 168
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 165
Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities 164
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles 163
Novel celecoxib analogues inhibit glial production of prostaglandinE2, nitric oxide, and oxygen radicals reverting the neuroinflammatoryresponses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide 160
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus 158
Organometallic compounds in oncology: implications of novel organotins as antitumor agents 156
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines 156
(+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype 155
Differential modulation of SIRT6 deacetylase and deacylase activities by lysine-based small molecules 155
The Influence of the Nitrogen Substitution in Three Cytisine Derivatives as Ligands for the Neuronal nAChRs: A Structural and Theoretical Study 152
Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and beta-Amyloid (Abeta) Aggregation 151
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation 149
Novel Quinolizidinyl Derivatives as Antiarrhythmic Agents 149
N-Homolupinanoyl and N-(ω-lupinylthio)alkanoyl derivatives of some tricyclic systems as ligands for muscarinic M1 and M2 receptor subtypes 140
Epimerization of lupinine to epilupinine and vice versa. Reexamination of the structures of lupinal and epilupinal 140
Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity 140
In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo 137
Antitubercular and antiprotozoal activities of quinolizidinyl/pyrrolizidinylalkyliminophenazines 137
Celecoxib, a COX-2 inhibitor, blocks microglial activation induced by a neurotoxic conformer of hPrP90-231 137
New arylsparteine derivatives as positive inotropic drugs 137
On the self-condensation of aminoguanidine leading to 1,1,4,10,10-pentaamino-2,3,5,6,8,9-hexaazadeca-1,3,5,7,9-pentaene (Structure elucidation through X-ray powder diffraction) 136
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 135
Computational approaches for the design and chemical synthesis of novel F508del correctors in the treatment of cystic fibrosis 135
Synthesis and pharmacological evaluation of some thiolupinine derivatives 134
Synthesis, binding, and modeling studies of new cytisine derivatives as ligands for neuronal nicotinic acetylcholine receptor subtypes 131
New coumarin hybrids with antiproliferative activity against a neuroblastoma cell line 129
Short exposure to high concentrations of malondialdehyde does not mimic physiological conditions 129
Synthesis and structure-activity relationship of aminoarylthiazole derivatives as potential potentiators of the chloride transport defect in cystic fibrosis 128
Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors 125
Cap 10 - Recettori adrenergici e farmaci attivi sulla neurotrasmissione adrenergica 121
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease 116
Exploring the effectiveness of novel benzimidazoles as CB2 ligands: synthesis, biological evaluation, molecular docking studies and ADMET prediction 115
Cap 16 - Anestetici generali ed anestetici locali 114
Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease 101
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells 99
Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays 99
Journey on naphthoquinone and anthraquinone derivatives: New insights in alzheimer’s disease 98
Synthesis and biological investigation of 2-(tetrahydropyran-2'-yl) and 2-(tetrahydrofuran-2'-yl)-benzimidazoles 97
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays 96
Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors 95
Cap 11 - Recettori della serotonina e farmaci attivi sulla neurotrasmissione serotoninergica 94
Novel organotins as antitumor agents 92
Synthesis and antiplasmodial activity of novel chloroquine analogues with bulky basic side chains 92
Btk inhibitors: a medicinal chemistry and drug delivery perspective 89
Cap. 9 - Farmaci attivi sulla neurotrasmissione colinergica 88
Quinolizidinyl derivatives of bi- and tricyclic systems as AChE/BchE and beta-amyloid aggregation inhibitors, 87
Primary anti-proliferative activity evaluation of 1-(quinolizidin-1'-yl)methyl- and 1-([Formula: see text]-tert-amino)alkyl-substituted 2-phenyl-, 2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles on human cancer cell lines. 74
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives 73
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis 71
Synthesis and prelimary docking studies of new colchicine-benzotriazole hybrid compounds 69
BMI-1 inhibition fights cancer chemoresistance by altering redox homeostasis and inducing lipid peroxidation 69
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia 69
Microbiological Screening of 5-Functionalized Pyrazoles for the Future Development of Optimized Pyrazole-Based Delivery Systems 67
Quinone-based derivatives: a new class of multi-target agents against Alzheimer’s disease 65
Quinolizidine-derived lucanthone and amitriptyline analogues endowed with potent antileishmanial activity 60
New pyrazolyl thioureas active against the Staphylococcus genus 59
Indole Antitumor Agents in Nanotechnology Formulations: An Overview 58
Whey proteins inhibit food intake and tend to improve oxidative balance in obese zucker rats 56
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells 54
Further quinolizidine derivatives as antiarrhythmic agents-3 53
Glutathione in cancer progression and chemoresistance: an update 52
New naphtho- and anthraquinone derivatives as Cholinesterase inhibitors for the treatment of Alzheimer's disease 51
Design and synthesis of new coumarin hybrids with antiproliferative activity against neuroblastoma cells 50
New insights on Fak and Fak inhibitors 50
The Development of FAK Inhibitors: A Five-Year Update 47
null 38
NEW HYBRID COUMARIN–SUBSTITUTED ALICYCLIC AMINES AS POTENTIAL MULTITARGET DIRECT LIGANDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE 37
Hybrid molecules phenothiazine/cinnamic derivatives as MTDL and their biological evaluation 33
Nanotechnology for Pediatric Retinoblastoma Therapy 29
null 28
Nanotechnology of tyrosine kinase inhibitors in cancer therapy: A perspective 23
Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells 20
SYNTHESIS AND STRUCTURE–ACTIVITY RELATIONSHIP OF COUMARIN HYBRIDS WITH ANTIPROLIFERATIVE PROPERTIES AGAINST A MULTIDRUG-RESISTANT NEUROBLASTOMA CELL LINE 16
The Development of BTK Inhibitors: A Five-Year Update 15
New hybrids coumarins– substituted alicyclic amines as potential multi target direct ligands for the treatment of Alzheimer’s disease 12
Totale 9.192
Categoria #
all - tutte 31.057
article - articoli 26.702
book - libri 0
conference - conferenze 3.045
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.310
Totale 62.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021340 0 0 0 0 0 52 32 42 49 62 63 40
2021/2022866 38 48 79 83 31 46 47 190 46 69 48 141
2022/2023860 74 55 15 91 155 151 4 57 140 5 101 12
2023/2024512 21 86 19 82 27 70 20 46 19 17 55 50
2024/20251.716 41 106 58 96 210 180 195 310 66 76 193 185
2025/20261.663 395 86 324 340 461 57 0 0 0 0 0 0
Totale 9.192